Form: 10-K

Annual report pursuant to Section 13 and 15(d)

April 15, 2022

Exhibit 21.1

Subsidiaries of the Registrant

Jade Therapeutics, Inc.

(United States)

Kiora Pharmaceuticals GmbH

(Austria)

Bayon Therapeutics, Inc.

(United States)

Kiora Pharmaceuticals Pty Ltd

(Australia)